Kartos Therapeutics

Redwood City, CA · Founded 2018 · Privately Held (backing)

Operator of a biopharmaceutical company intended to offer investigational inhibitors for cancer treatment. Kartos Therapeutics is based in Redwood City, CA and was founded in 2018. It is valued at about $650 million as of Oct 2026, set by institutional fund marks. It has raised $265 million.

PMV mark · valuation
$650.0M
Oct 2026
Priced at
—
Total raised
$265.0M
Last round
—

Who backs Kartos Therapeutics?

4 investors
InvestorType
OrbiMedGrowth equity
SR One Capital ManagementOther
Amgen—
Quogue Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kartos Therapeutics investors

4 investors are on record for Kartos Therapeutics, including OrbiMed, SR One Capital Management, Amgen and Quogue Capital.

Free account
More of Kartos Therapeutics with a free account
  • ·Watch Kartos Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Kartos Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View